Literature DB >> 1730412

Max: functional domains and interaction with c-Myc.

G J Kato1, W M Lee, L L Chen, C V Dang.   

Abstract

The product of the c-myc proto-oncogene is a DNA-binding protein, the deregulated expression of which is associated with a variety of malignant neoplasms. The cDNA for the max gene was recently cloned as a result of the ability of its protein product to interact with the c-Myc protein. We studied bacterially produced Max, c-Myc, and a series of truncated c-Myc proteins. Full-length c-Myc alone cannot bind DNA. However, a truncated c-Myc protein comprising the basic, helix-loop-helix, and leucine zipper regions can bind specifically to DNA bearing the sequence GGGCAC(G/A)TGCCC. Max protein, either alone or in a heteromeric complex with full-length c-Myc, binds to the same core sequence. Using a novel combination of chemical and photo-cross-linking analysis, we demonstrate that either Max or a c-Myc/Max heteromeric complex binds to DNA virtually exclusively in a dimeric structure. Using fusion proteins in cultured cells, we establish a number of functional characteristics of Max. First, we show that Max can interact with c-Myc intracellularly in a manner dependent on the integrity of the helix-loop-helix and leucine zipper motifs. Second, a nuclear localization domain that contains the sequence PQSRKKLR is mapped to the carboxy-terminal region of Max. Third, Max lacks a transcriptional activation domain that is functional in Chinese hamster ovary cells when fused to a heterologous DNA-binding domain. These data suggest that Max may serve as a cofactor for c-Myc in transcriptional activation or, by itself, as a transcriptional repressor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730412     DOI: 10.1101/gad.6.1.81

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  98 in total

Review 1.  The Max network gone mad.

Authors:  T A Baudino; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells.

Authors:  Asya V Grinberg; Chang-Deng Hu; Tom K Kerppola
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

3.  A role for c-myc in chemically induced renal-cell death.

Authors:  Y Zhan; J L Cleveland; J L Stevens
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

4.  A functional role for death proteases in s-Myc- and c-Myc-mediated apoptosis.

Authors:  S Kagaya; C Kitanaka; K Noguchi; T Mochizuki; A Sugiyama; A Asai; N Yasuhara; Y Eguchi; Y Tsujimoto; Y Kuchino
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

5.  Expression and activity of L-Myc in normal mouse development.

Authors:  K S Hatton; K Mahon; L Chin; F C Chiu; H W Lee; D Peng; S D Morgenbesser; J Horner; R A DePinho
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

6.  Myc and Max: molecular evolution of a family of proto-oncogene products and their dimerization partner.

Authors:  W R Atchley; W M Fitch
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

7.  The effect of cyclic-AMP on the regulation of c-myc expression in T lymphoma cells.

Authors:  D A Albert
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors.

Authors:  B Roy; J Beamon; E Balint; D Reisman
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

9.  An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc.

Authors:  S Gaubatz; A Meichle; M Eilers
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

10.  Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1.

Authors:  E G Lahoz; L Xu; N Schreiber-Agus; R A DePinho
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.